Guía de práctica clínica (GPC): guía de GELTAMO para diagnóstico, prevención y manejo terapéutico de la afectación del sistema nervioso central en pacientes con linfoma b difuso de célula grande

Javier Peñalver, Francisco; Fuente, Adolfo de la; Olave, Teresa; Orfao, Alberto; Sancho, Juan Manuel.
Madrid; Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea; 2015.
Monografía en Español | BIGG | ID: biblio-964216

Documentos relacionados

  1. [Pathobiology and its clinical relevance in diffuse large B-cell lymphoma].
  2. Limited-stage diffuse large B-cell lymphoma.
  3. Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
  4. Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
  5. Recommendations for an Approach to Random Skin Biopsy in the Diagnosis of Intravascular B-Cell Lymphoma.
  6. Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
  7. Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
  8. Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome.
  9. Random Skin Biopsy for Diagnosis of Intravascular Large B-Cell Lymphoma: A Case Report and Literature Review.
  10. Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapy.